SAN JOSE, California and
NEW YORK, Nov. 12, 2019 /PRNewswire/ -- Global digital
therapeutics innovation leader, DarioHealth Corp. (NASDAQ: DRIO)
announced today the launch of a Dario-powered digital diabetes
program with Action Urgent Care.
Action Urgent Care has experienced rapid growth since its first
clinic opened in San Jose in 2013,
to more than 40 points of care they operate throughout California today. Some clinics have their own
premises, while others are located inside Safeway and Vons
supermarkets. The clinics offer a broad range of services including
walk-ins for immediate care, primary care, specialized medicine,
physical exams, diagnostics, preventative screenings and
immunizations. Action Urgent Care uses state-of-the-art technology,
including its mobile application which creates a superior user
experience for patients. Action Urgent Care will now offer
MyDario™ as an additional application within its
mobile platform.
The MyDario™ user app digitally manages
chronic conditions and is among the most downloaded and highest
rated healthcare apps, with 4.9/5.0 stars over 8,000+ reviews on
the Apple store. Its Net Promoter Score (NPS), a measure of
willingness of customers to recommend a company's products or
services to others, is +77, considered "world class" and the
highest in its category, on a -100 to +100 scale.
"We are always looking to improve our patient care with advanced
digital solutions. We believe complementing care in between office
visits with digital interventions is essential to manage chronic
conditions as it establishes and reinforces healthy habits in our
patient population. Given its leadership position in digital
therapeutics, Dario was an obvious choice. We are excited to offer
access to Dario as part of our own mobile application"
commented Garick Hismatullin, CEO Action Urgent Care."
"We are proud to offer Action Urgent Care physicians our
complete digital solution to help manage their patients' diabetes
and hypertension as chronic conditions. Digital therapeutics can
complement doctor appointments while also making visits more
efficient via our healthcare professional application,
DarioEngage™. Dario conducts several clinical studies
every year that demonstrate superior medical outcomes such as 30%
to 45% of diabetes type 2 users reaching an average blood glucose
of 140mg/dL or less" mentioned Olivier
Jarry, DarioHealth's president and chief commercial
officer.
About DarioHealth Corp.
DarioHealth Corp. (NASDAQ: DRIO) is a leading global digital
health company serving its users with dynamic mobile health
solutions. In today's day and age, knowledge of health and
treatment is being democratized, and we believe people deserve to
know everything about their own health and have the best tools to
manage their condition. DarioHealth employs a revolutionary
approach whereby harnessing big data, we have developed a novel
method for chronic disease data management, empowering people to
analyze and personalize self-diabetes management in a totally new
way without having the disease slow them down. DarioHealth has a
commercial office in New York with
an R&D center in Caesarea,
Israel.
For more information, visit
http://mydario.investorroom.com/.
About Action Urgent Care
Action Health consists of several innovative healthcare
organizations.
Action Urgent Care:
Action Urgent Care launched its first clinic in January of 2013.
Since that time Action has grown to 5 clinics and significantly
expanded the scope of its services. The company now treats over
70,000 patients annually, making it one of the largest privately
held medical entities in the Bay Area.
Action Health Clinics:
Action Health Clinics provides complete multi-specialty care
inside of grocery retail centers. The first Action Health Clinic
opened in January of 2018. There are currently 40 clinics in
California.
For more information, visit http://actionurgentcare.com/.
Cautionary Note Regarding Forward-Looking Statements
This news release and the statements of representatives and
partners of DarioHealth Corp. (the "Company") related thereto
contain or may contain forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995.
Statements that are not statements of historical fact may be deemed
to be forward-looking statements. Without limiting the generality
of the foregoing, words such as "plan," "project," "potential,"
"seek," "may," "will," "expect," "believe," "anticipate," "intend,"
"could," "estimate," or "continue" are intended to identify
forward-looking statements. Readers are cautioned that certain
important factors may affect the Company's actual results and could
cause such results to differ materially from any forward-looking
statements that may be made in this news release. Factors that may
affect the Company's results include, but are not limited to,
regulatory approvals, product demand, market acceptance, impact of
competitive products and prices, product development,
commercialization or technological difficulties, the success or
failure of negotiations and trade, legal, social and economic
risks, and the risks associated with the adequacy of existing cash
resources. Additional factors that could cause or contribute to
differences between the Company's actual results and
forward-looking statements include, but are not limited to, those
risks discussed in the Company's filings with the U.S. Securities
and Exchange Commission. Readers are cautioned that actual results
(including, without limitation, the timing for and results of the
Company's commercial and regulatory plans for Dario™) may differ
significantly from those set forth in the forward-looking
statements. The Company undertakes no obligation to publicly update
any forward-looking statements, whether as a result of new
information, future events or otherwise, except as required by
applicable law.
DarioHealth Corporate Contact:
Claudia
Levi
Content & Communications Manager
claudia@mydario.com
+1 347-767-4220
View original
content:http://www.prnewswire.com/news-releases/action-urgent-care-selects-mydario-300956212.html
SOURCE DarioHealth Corp.